GALWAY, Ireland & NORTHBOROUGH, Mass.--(BUSINESS WIRE)--Creganna-Tactx Medical and Boston Biomedical Associates (BBA) today announced a joint venture partnership under which Creganna-Tactx Medical customers will have dedicated access to clinical, regulatory and quality expertise and consulting services. The joint venture company will be co-located at BBA’s Massachusetts & California facilities and staffed by experienced regulatory and quality professionals who will have a dedicated focus on Creganna-Tactx Medical customers.
